A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
about
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A 12-week randomized controlle ...... in people with schizophrenia.
@en
A 12-week randomized controlle ...... in people with schizophrenia.
@nl
type
label
A 12-week randomized controlle ...... in people with schizophrenia.
@en
A 12-week randomized controlle ...... in people with schizophrenia.
@nl
prefLabel
A 12-week randomized controlle ...... in people with schizophrenia.
@en
A 12-week randomized controlle ...... in people with schizophrenia.
@nl
P2093
P2860
P1476
A 12-week randomized controlle ...... in people with schizophrenia.
@en
P2093
Cort A Pedersen
David L Penn
Jacqueline L Johnson
L Fredrik Jarskog
Robert M Hamer
Shane W Rau
Tonya Elliott
P2860
P356
10.1016/J.SCHRES.2017.01.008
P407
P577
2017-01-13T00:00:00Z